Aclaris Therapeutics, Inc. Annual Return On Assets in % from 2016 to 2023

Taxonomy & unit
ratio: %
Description
Return on assets can be defined as an indicator of how profitable a company is relative to its total assets. Calculated by dividing a company's operating earnings by its total assets.
Summary
Aclaris Therapeutics, Inc. quarterly/annual Return On Assets history and growth rate from 2016 to 2023.
  • Aclaris Therapeutics, Inc. Return On Assets for the quarter ending September 30, 2024 was -20.7 %, a 57.6% increase year-over-year.
  • Aclaris Therapeutics, Inc. annual Return On Assets for 2023 was -40.2 %, a 18.6% decline from 2022.
  • Aclaris Therapeutics, Inc. annual Return On Assets for 2022 was -33.9 %, a 10.2% increase from 2021.
  • Aclaris Therapeutics, Inc. annual Return On Assets for 2021 was -37.7 %, a 40.1% increase from 2020.
Return On Assets, Annual (%)
Return On Assets, YoY Annual Growth (%)
Period Value YoY Chg Change % Start Date End Date
2023 -40.2 -6.31 -18.6% Jan 1, 2023 Dec 31, 2023
2022 -33.9 +3.84 +10.2% Jan 1, 2022 Dec 31, 2022
2021 -37.7 +25.2 +40.1% Jan 1, 2021 Dec 31, 2021
2020 -62.9 +25.6 +29% Jan 1, 2020 Dec 31, 2020
2019 -88.5 -27.8 -45.7% Jan 1, 2019 Dec 31, 2019
2018 -60.7 -28.4 -87.9% Jan 1, 2018 Dec 31, 2018
2017 -32.3 +10.8 +25.1% Jan 1, 2017 Dec 31, 2017
2016 -43.2 Jan 1, 2016 Dec 31, 2016
* An asterisk sign (*) next to the value indicates that the value is likely invalid.